Related Experiment Video
Updated: May 25, 2026
09:39
Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
Investigation of a new injectable thermosensitive hydrogel loading solid lipid nanoparticles
Xinhong Guo1, Fude Cui, Yabing Xing
1Department of Pharmaceutical Sciences, Shenyang Pharmaceutical University, Shenyang, China. gxh371@126.com
Die Pharmazie
|February 9, 2012
Summary
This study developed an injectable hydrogel loaded with solid lipid nanoparticles (SLN) carrying 2-methoxyestradiol (2-ME) for improved cancer chemotherapy. The hydrogel demonstrated sustained release of intact SLN for over 46 days, enhancing drug delivery potential.
Area of Science:
- Biomedical Engineering
- Materials Science
- Pharmacology
Background:
- Solid lipid nanoparticles (SLN) offer potential for drug delivery but face rapid systemic clearance.
- Improving the sustained release and targeted delivery of SLN is crucial for enhancing cancer chemotherapy effectiveness.
Purpose of the Study:
- To develop an injectable, thermo-sensitive hydrogel system for encapsulating and controlling the release of 2-methoxyestradiol (2-ME) loaded SLN.
- To evaluate the stability, release kinetics, and physicochemical properties of the SLN-loaded hydrogel for improved cancer chemotherapy.
Main Methods:
- Development of an injectable hydrogel using PLGA-PEG-PLGA loaded with 2-ME SLN.
- Characterization of SLN integrity using scanning electron microscopy (SEM) and particle size analysis.
- In vitro release studies, assessment of thermo-sensitive properties, and rheological behavior analysis.
Main Results:
- The developed hydrogel successfully encapsulated intact SLN, maintaining their integrity.
- Prolonged in vitro release of intact 2-ME SLN from the hydrogel was observed for over 46 days.
- The SLN-loaded hydrogel exhibited reversible thermo-sensitive properties and improved syringeability, with drug concentration significantly impacting release rate.
Conclusions:
- The injectable SLN-loaded hydrogel system provides a promising platform for sustained delivery of 2-ME, potentially improving cancer chemotherapy efficacy.
- The hydrogel's ability to protect SLN and control their release suggests enhanced therapeutic outcomes by maintaining therapeutic drug concentrations at the target site.
